Literature DB >> 14632732

Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion Multicolour-FISH in the detection of urothelial carcinoma.

C Mian1, M Lodde, E Comploj, G Negri, E Egarter-Vigl, L Lusuardi, S Palermo, M Marberger, A Pycha.   

Abstract

The aim of the study was to assess the value of liquid-based urinary cytology as a tool to perform uCyt+ and Multicolour-FISH in patients under follow-up after urothelial cancer. Therefore, standard cytology was compared to liquid-based cytology with the addition of the uCyt+ test, which traces the three monoclonal antibodies M344, LDQ10 and 19A211 in exfoliated urothelial cells; and Multicolour-FISH (including centromere-specific probes for chromosomes 3, 7, 17 and a locus-specific probe for 9p21/p16) performed on thin-layer specimens. UCyt+ showed an overall sensitivity of 86.2% and cytology of 45.0%. Overall sensitivity of both the tests combined was 90%. Sensitivity of Multicolour-FISH was 96.4%. All conventional cytology diagnoses were confirmed by liquid-based cytology. Liquid-based cytology is a valid tool for the performance of adjunctive analyses, such as uCyt+ and Multicolour-FISH, on residual cellular material.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632732     DOI: 10.1046/j.0956-5507.2003.00094.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  7 in total

1.  Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?

Authors:  F Steffen Krause; Anita Rauch; Karl M Schrott; Dirk G Engehausen
Journal:  World J Urol       Date:  2006-05-11       Impact factor: 4.226

2.  Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer.

Authors:  Kirsten L Greene; Anna Berry; Badrinath R Konety
Journal:  Rev Urol       Date:  2006

3.  Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma.

Authors:  Xiaopeng Mao; Baimou Li; Ying Liang; Shuhua Li; Jianwen Zhou; Qiong He; Neng Jiang; Yangshan Chen; Yu Sun; Yongmei Cui; Wenting Jiang; Han Wang; Liantang Wang; Zunfu Ke
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

4.  Diagnosis of bladder cancer from the voided urine specimens using multi-target fluorescence in situ hybridization.

Authors:  Zunfu Ke; Yuanhua Lai; Xudong Ma; Shuhua Lil; Wenhua Huang
Journal:  Oncol Lett       Date:  2013-12-09       Impact factor: 2.967

Review 5.  Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.

Authors:  Bénédicte Clin; Jean-Claude Pairon
Journal:  BMC Public Health       Date:  2014-11-06       Impact factor: 3.295

Review 6.  Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?

Authors:  Nada Humayun-Zakaria; Douglas G Ward; Roland Arnold; Richard T Bryan
Journal:  Transl Androl Urol       Date:  2021-06

7.  Introduction and utility of liquid-based cytology on aspiration biopsy of peripheral nodular lesions of the lung.

Authors:  Johji Imura; Kaori Abe; Yoshiaki Uchida; Masaharu Shibata; Kazue Tsunematsu; Motohiro Sathoh; Shigeharu Miwa; Takahiko Nakajima; Kazuhiro Nomoto; Shinichi Hayashi; Koichi Tsuneyama
Journal:  Oncol Lett       Date:  2013-12-17       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.